title: Iatrogenic Creutzfeldt-Jakob disease 22 years after human growth hormone therapy: clinical and radiological features.
authors.forename: M
authors.initials: M
authors.lastname: Furtner
authors.forename: E
authors.initials: E
authors.lastname: Gelpi
authors.forename: S
authors.initials: S
authors.lastname: Kiechl
authors.forename: M
authors.initials: M
authors.lastname: Knoflach
authors.forename: A
authors.initials: A
authors.lastname: Zangerl
authors.forename: T
authors.initials: T
authors.lastname: Gotwald
authors.forename: J
authors.initials: J
authors.lastname: Willeit
authors.forename: H
authors.initials: H
authors.lastname: Maier
authors.forename: T
authors.initials: T
authors.lastname: Ströbel
authors.forename: U
authors.initials: U
authors.lastname: Unterberger
authors.forename: H
authors.initials: H
authors.lastname: Budka
mesh_terms: D000315:Adrenalectomy; D000328:Adult; D001921:Brain / Q000473:pathology; D007562:Creutzfeldt-Jakob Syndrome / Q000175:diagnosis / Q000473:pathology / Q000635:transmission*; D003480:Cushing Syndrome / Q000601:surgery; D003937:Diagnosis, Differential; D038524:Diffusion Magnetic Resonance Imaging; D018450:Disease Progression; D004340:Drug Contamination; D004393:Dwarfism, Pituitary / Q000188:drug therapy; D004569:Electroencephalography; D005500:Follow-Up Studies; D006429:Hemiplegia / Q000209:etiology; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007016:Hypophysectomy; D007049:Iatrogenic Disease; D008279:Magnetic Resonance Imaging; D008297:Male; D009483:Neuropsychological Tests; D010292:Paresthesia / Q000209:etiology; D010911:Pituitary Neoplasms / Q000601:surgery; D011183:Postoperative Complications / Q000188:drug therapy; D011596:Psychomotor Disorders / Q000209:etiology; D012086:Reoperation
chemical_list: D019382:Human Growth Hormone